WHO Pharmaceuticals Newsletter 1999, No. 05&06
(1999; 20 pages)
Table des matières
Ouvrir ce répertoire et afficher son contenuRegulatory actions
Ouvrir ce répertoire et afficher son contenuDrug surveillance
Ouvrir ce répertoire et afficher son contenuNew developments
Ouvrir ce répertoire et afficher son contenuMedical devices
Ouvrir ce répertoire et afficher son contenuMedication errors
Ouvrir ce répertoire et afficher son contenuGeneral information
Fermer ce répertoireVeterinary medicine
Afficher le documentBacitracin methylene disalicylate soluble: approved for prevention and control of necrotic enteritis: United States of America.
Afficher le documentEprinomectin: approved for treatment of parasites in cattle: Switzerland.
Afficher le documentMicrobial effects of antimicrobial new animal drugs: assuring human safety: United States of America.
 

Bacitracin methylene disalicylate soluble: approved for prevention and control of necrotic enteritis: United States of America.

The Food and Drug Administration has approved the use of soluble bacitracin methylene disalicylate powder to make a medicated drinking water for replacement chickens as an aid in the prevention and control of necrotic enteritis. The dosage is 100 mg per gallon for prevention and 200 mg to 400 mg of bacitracin methylene disalicylate for control of necrotic enteritis caused by Clostridium perfringens.

Reference: Federal Register 64(51): 13068 (1999).

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012